Can 1 capsule of magnesium glycinate (Pure Encapsulations) 120mg elemental magnesium cause tachycardia or arrhythmia in a patient with normal kidney function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Magnesium Glycinate 120mg Cause Cardiac Arrhythmias in Normal Kidney Function?

No, a single 120mg elemental magnesium capsule (Pure Encapsulations magnesium glycinate) will not cause tachycardia or arrhythmias in patients with normal kidney function. This dose is well below toxic thresholds and represents a standard supplementation amount.

Physiologic Context

  • Normal serum magnesium ranges from 1.3 to 2.2 mEq/L (0.65-1.1 mmol/L), and magnesium toxicity typically begins when serum levels exceed 2.4 mg/dL (>1.2 mmol/L) 1
  • The kidney normally excretes approximately two-thirds of filtered magnesium, providing robust protection against toxicity in patients with normal renal function 1
  • Magnesium plays a key role in modulating cardiac neuronal excitation, intracardiac conduction, and myocardial contraction by regulating ion channels including potassium and calcium channels 2

Why This Dose Is Safe

  • Dose magnitude: 120mg elemental magnesium is a modest supplementation dose, far below amounts associated with toxicity 1, 3
  • Renal clearance: With normal kidney function, excess magnesium is efficiently excreted, preventing accumulation 1
  • Oral absorption: Oral magnesium has limited and self-regulating absorption from the gastrointestinal tract, unlike intravenous administration 4, 5

When Magnesium Causes Cardiac Effects

Magnesium's cardiac effects are bidirectional and dose-dependent:

Therapeutic cardiac uses (at appropriate doses):

  • Magnesium is specifically used to treat certain arrhythmias, particularly polymorphic VT with QT prolongation (torsades de pointes), at doses of 1-2 grams IV 6
  • It can be valuable in treating both hypomagnesemic and digitalis-toxic tachyarrhythmias 7

Toxic cardiac effects (only at very high serum levels):

  • Bradycardia and hypotension occur with magnesium toxicity, not tachycardia 6, 1
  • Early signs include loss of deep tendon reflexes, followed by hypotension and bradycardia at higher levels 1
  • Cardiac arrest can occur, but only with severe hypermagnesemia (serum levels >9-11 mg/dL) 4, 5, 8

Critical Risk Factors for Toxicity (None Apply Here)

Hypermagnesemia requiring clinical concern occurs primarily in these scenarios:

  • Renal impairment: Creatinine clearance <20 mL/min represents an absolute contraindication for magnesium supplementation 1
  • Massive doses: Cases of fatal hypermagnesemia involved patients taking 3,000mg daily of magnesium hydroxide or massive laxative overdoses 5, 8
  • Bowel obstruction: Impaired GI motility increases absorption time and toxicity risk 4
  • Repeated high-dose administration: Not single standard doses 1

Common Pitfall to Avoid

Do not confuse hypomagnesemia with hypermagnesemia effects: Low magnesium causes arrhythmias (including tachyarrhythmias), while high magnesium causes bradycardia and conduction blocks 6, 2, 7. A patient experiencing palpitations or tachycardia on magnesium supplementation more likely has:

  • Coincidental timing unrelated to the supplement
  • Pre-existing arrhythmia substrate
  • Concurrent electrolyte abnormalities (hypokalemia, hypocalcemia often coexist with hypomagnesemia) 3

Clinical Bottom Line

A single 120mg elemental magnesium capsule poses no cardiac risk in patients with normal kidney function. The dose is physiologic, renal excretion is intact, and oral absorption is self-limiting. Cardiac arrhythmias from magnesium occur only with severe toxicity (serum levels >9 mg/dL) from massive ingestions or renal failure—scenarios completely inapplicable to this clinical question 4, 5, 8.

References

Guideline

Magnesium Toxicity Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Magnesium and Cardiovascular Disease.

Advances in chronic kidney disease, 2018

Guideline

Magnesium Level Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fatal Hypermagnesemia in Patients Taking Magnesium Hydroxide.

Electrolyte & blood pressure : E & BP, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Magnesium deficiency and cardiac disorders.

The American journal of medicine, 1975

Research

Acute hypermagnesemia after laxative use.

Annals of emergency medicine, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.